AU2003244978A1 - Methods to identify anti-tumoral agents inhibiting rasgap / aurora kinase interactions - Google Patents

Methods to identify anti-tumoral agents inhibiting rasgap / aurora kinase interactions

Info

Publication number
AU2003244978A1
AU2003244978A1 AU2003244978A AU2003244978A AU2003244978A1 AU 2003244978 A1 AU2003244978 A1 AU 2003244978A1 AU 2003244978 A AU2003244978 A AU 2003244978A AU 2003244978 A AU2003244978 A AU 2003244978A AU 2003244978 A1 AU2003244978 A1 AU 2003244978A1
Authority
AU
Australia
Prior art keywords
rasgap
methods
aurora kinase
identify anti
agents inhibiting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003244978A
Other versions
AU2003244978A8 (en
Inventor
Jacques Camonis
Christiane Garbay
Veronique Gigoux
Sebastien L'hoste
Jerome Samson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Publication of AU2003244978A8 publication Critical patent/AU2003244978A8/en
Publication of AU2003244978A1 publication Critical patent/AU2003244978A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity
    • G01N2333/4706—Regulators; Modulating activity stimulating, promoting or activating activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/82—Translation products from oncogenes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2003244978A 2002-04-15 2003-04-15 Methods to identify anti-tumoral agents inhibiting rasgap / aurora kinase interactions Abandoned AU2003244978A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37248302P 2002-04-15 2002-04-15
US60/372,483 2002-04-15
PCT/IB2003/002972 WO2003087395A2 (en) 2002-04-15 2003-04-15 Methods to identify anti-tumoral agents inhibiting rasgap / aurora kinase interactions

Publications (2)

Publication Number Publication Date
AU2003244978A8 AU2003244978A8 (en) 2003-10-27
AU2003244978A1 true AU2003244978A1 (en) 2003-10-27

Family

ID=29250860

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003244978A Abandoned AU2003244978A1 (en) 2002-04-15 2003-04-15 Methods to identify anti-tumoral agents inhibiting rasgap / aurora kinase interactions

Country Status (2)

Country Link
AU (1) AU2003244978A1 (en)
WO (1) WO2003087395A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1812439B2 (en) 2004-10-15 2017-12-06 Takeda Pharmaceutical Company Limited Kinase inhibitors
US8119655B2 (en) 2005-10-07 2012-02-21 Takeda Pharmaceutical Company Limited Kinase inhibitors
US20100120717A1 (en) 2006-10-09 2010-05-13 Brown Jason W Kinase inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001284454A1 (en) * 2000-09-08 2002-03-22 Chugai Research Institute For Molecular Medicine, Inc. Method of screening antitumor agent by using interaction between arf protein and hk33 protein

Also Published As

Publication number Publication date
AU2003244978A8 (en) 2003-10-27
WO2003087395A2 (en) 2003-10-23
WO2003087395A3 (en) 2004-03-04

Similar Documents

Publication Publication Date Title
IL172375A0 (en) Chinazoline derivatives as aurora kinase inhibitors
AP2048A (en) Diazepinoindole derivatives as kinase inhibitors
IL189658A0 (en) N-phenyl-2-pyrimidine-amine derivatives
IL173381A0 (en) 2-aminophenyl-4-phenylpyrimidines as kinase inhibitors
ZA200604352B (en) Azepinondole derivatives as pharmaceutical agents
IL165515A0 (en) Bisindolyl-maleimid derivatives as kinase inhibitors
IL172132A0 (en) Thienopyridone derivatives as kinase inhibitors
AU2003271566A8 (en) Pyrrolopyrazines as kinase inhibitors
AU2003301302A1 (en) Pyradazine compounds as gsk-3 inhibitors
EP1664316A4 (en) Polyethyleneglycol-modified lipid compounds and uses thereof
IL176562A0 (en) Amidopyrazole derivative
AU2003237446A1 (en) Pyrazole-derivatives as p38 kinase inhibitors
IL172257A0 (en) Substituted pyrrole derivatives and their use as hmg-co inhibitors
HK1079984A1 (en) Glycinamide derivative for inhibiting hiv replication
EP1572950A3 (en) Single domain tdf-related compounds and analogs thereof
EP1572950A4 (en) Single domain tdf-related compounds and analogs thereof
AU2003902882A0 (en) Piperidyl derivatives
AU2003277444A8 (en) Two-way ranging techniques
AU2003244978A1 (en) Methods to identify anti-tumoral agents inhibiting rasgap / aurora kinase interactions
GB0311195D0 (en) Glyoxalase inhibitors
AU2003276752A1 (en) Multiple domain tdf-related compounds and analogs thereof
AU2003232362A8 (en) 4-pyrazol-phenylalanine derivatives as ace-nep inhibitors
PL376540A1 (en) Diazepanes derivatives useful as lfa inhibitors
AU2003280821A8 (en) Beauveriolide derivative
AU2003253008A1 (en) Indolylalkylamino-methylidenecarbamate derivatives useful as gnrh antagonists

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase